 Mirati Therapeutics, Inc. NASDAQ:MRTX Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Ryan Asay - Vice President of Corporate Affairs David Meek - Chief Executive Officer Chuck Baum - President, Founder Head of Research Development Laurie Stelzer - Chief Financial Officer Jamie Christensen - Chief Scientific Officer Ben Hickey - Chief Commercial Officer Conference Call Participants Michael Schmidt - Guggenheim Tyler Van Buren - Cowen Jonathan Miller - Evercore Ben Burnett - Stifel Andrew Berens - SVB Securities Evan Seigerman - BMO Capital Markets Yigal Nochomovitz - Citi Mike Ulz - Morgan Stanley Maury Raycroft - Jefferies Jay Olson - Oppenheimer Operator Good afternoon, and welcome to the Mirati Therapeutics Second Quarter 2022 Earnings Call. My name is Danielle, and I will be the operator for todays call. 